Caring for patients being treated for relapsed/refractory multiple myeloma (MM) presents unique challenges. Recognizing the signs of relapse is essential, as is understanding adverse events associated with common treatment regimens for MM over time. Learn about the many considerations for treating MM in a relapsed/refractory setting, including possible treatment side effects and patient education. This case focuses on understanding risks associated with certain treatments, and possible alternative treatments.
If you haven't yet completed Part 1, check out Management of Multiple Myeloma for Oncology Nurses Part 1: Newly Diagnosed Multiple Myeloma.
You will enjoy access for 180 days from date of purchase, after which you will no longer be able to access the course.
Development of this resource was supported by Janssen Oncology.